| Dr Sheila Dawn Spain, LMFT | |
|
12250 Sw 2nd St Ste A, Beaverton, OR 97005 | |
| (425) 418-9515 | |
| (503) 601-0049 |
| Full Name | Dr Sheila Dawn Spain |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 12250 Sw 2nd St Ste A, Beaverton, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750439881 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | LF00001180 (Washington) | Secondary |
| 106H00000X | Marriage & Family Therapist | T1127 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sheila Dawn Spain, LMFT 14175 Sw Cougar Ridge Dr, Beaverton, OR 97008-9419 Ph: (425) 418-9515 | Dr Sheila Dawn Spain, LMFT 12250 Sw 2nd St Ste A, Beaverton, OR 97005 Ph: (425) 418-9515 |
News Archive
A new federal grant focusing on painful inherited visual disorders that scar the cornea will allow researchers to narrow the genetic cause of one type of corneal dystrophy and to offer improved diagnosis of this family of diseases.
Boehringer Ingelheim and Eli Lilly and Company today announced results of a 102 week Phase III study for linagliptin, which show meaningful and durable reductions in blood glucose for adults with type 2 diabetes.
Withdrawal of life-sustaining support and withholding lifesaving measures (such as CPR) appear to be the primary modes of infant deaths in a neonatal intensive care unit, according to a report in the July issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
MEDIAN Technologies, the leading provider of clinical applications for quantitative management of treatment responses in oncology imaging, today announced that it had obtained "Innovative Company" accreditation from OSEO (the French state innovation agency). This accreditation enables innovation-focused French investment funds (Fonds Communs de Placement dans l'Innovation) to invest in MEDIAN Technologies and enjoy a number of fiscal advantages.
Delcath Systems, Inc., a medical technology company developing the Delcath Percutaneous Hepatic Perfusion (PHP(TM)) System, a minimally invasive drug delivery platform for the regional treatment of cancer metastatic to the liver, today reported on the Company's recent progress.
› Verified 2 days ago
Mrs. Jennifer Fergusson, MA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 9670 Sw Beaverton Hillsdale Hwy, Beaverton, OR 97005 Phone: 503-646-8401 | |
Chelsea Amber Preston, M.A. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7950 Sw Magnolia Pl, Beaverton, OR 97008 Phone: 949-371-7398 | |
Crystal Stachera, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 6800 Sw 105th Ave Ste 101, Beaverton, OR 97008 Phone: 971-200-1966 Fax: 971-754-4141 | |
Ms. Alice Maureen Williams, LPC, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 12655 Sw Center Street, Suite 470, Beaverton, OR 97005 Phone: 503-227-2150 Fax: 888-972-8764 | |
Andrew Bradbury, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4145 Sw Watson Ave Ste 350, Beaverton, OR 97005 Phone: 971-203-2326 | |
Mr. Noah Carolan, M.ED Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1500 Nw Bethany Blvd Suite 320, Beaverton, OR 97006 Phone: 541-968-6624 | |
Susan Denton, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 12720 Sw 3rd St, Beaverton, OR 97005 Phone: 503-620-1191 |